JOSEPH ROMAN, MD

Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use

New patient office or other outpatient visit, 45-59 minutes

Transitional care management services for problem of at least moderate complexity

Established patient office or other outpatient visit, 40-54 minutes

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Established patient office or other outpatient visit, 30-39 minutes

Advance care planning, first 30 minutes

Established patient office or other outpatient visit, 20-29 minutes

Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and

Influenza vaccine split virus, preservative free

Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a

Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza

Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional

Administration of pneumococcal vaccine

Administration of vaccine

Injection of drug or substance under skin or into muscle

Administration of influenza virus vaccine

Annual depression screening, 5 to 15 minutes

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report

Injection, methylprednisolone acetate, 40 mg